RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.08B
AUM Growth
-$217M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1
+$174M
2
+$103M
3
+$74.5M
4
TSHA icon
Taysha Gene Therapies
TSHA
+$58.4M
5
APGE icon
Apogee Therapeutics
APGE
+$42.1M

Top Sells

1
+$365M
2
+$47.4M
3
+$30.3M
4
DSGN icon
Design Therapeutics
DSGN
+$18.7M
5
CVAC icon
CureVac
CVAC
+$11.2M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1B 19.76%
10,719,555
-505,802
2
$421M 8.28%
6,264,707
3
$402M 7.92%
7,891,254
4
$211M 4.16%
13,322,288
+10,992,330
5
$176M 3.47%
11,416,948
6
$137M 2.7%
532,892
7
$130M 2.56%
5,676,067
8
$112M 2.21%
236,114
9
$103M 2.04%
+6,940,000
10
$103M 2.03%
6,317,990
11
$99.6M 1.96%
7,236,454
12
$98.9M 1.95%
17,202,009
13
$97.9M 1.93%
46,202,425
+14,657,619
14
$95.8M 1.89%
7,809,852
15
$92.4M 1.82%
9,165,652
+495,008
16
$89.3M 1.76%
5,551,295
+1,777,778
17
$86.7M 1.71%
4,724,207
+870,340
18
$85.1M 1.68%
3,052,796
19
$83.3M 1.64%
9,000,000
20
$74.5M 1.47%
+2,736,680
21
$72.4M 1.43%
10,604,344
-1,641,611
22
$69.9M 1.38%
1,000,000
23
$62.6M 1.23%
6,416,147
24
$62M 1.22%
14,932,063
+5,161,290
25
$58.4M 1.15%
+18,472,503
1
2 3